Franklin Resources Inc Dyne Therapeutics, Inc. Transaction History

Franklin Resources Inc

$330 Billion
Q1 2025

A detailed history of Franklin Resources Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 1,414,835 shares of DYN stock, worth $14.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,414,835

Previous 1,323,803 6.88%

Holding current value

$14.1 Million

Previous $31.2 Million 52.55%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$10.46 - $25.46 $952,194 - $2.32 Million	91,032 Added 6.88%	1,414,835 $14.8 Million
Q4 2024 Feb 12, 2025	SELL	$23.56 - $35.55 $440,501 - $664,678	-18,697 Reduced 1.39%	1,323,803 $31.2 Million
Q3 2024 Nov 12, 2024	SELL	$31.94 - $47.04 $11.9 Million - $17.5 Million	-371,996 Reduced 21.7%	1,342,500 $48.2 Million
Q2 2024 Aug 14, 2024	SELL	$23.65 - $35.63 $1.63 Million - $2.45 Million	-68,775 Reduced 3.86%	1,714,496 $60.5 Million
Q1 2024 May 13, 2024	SELL	$13.06 - $29.18 $1.71 Million - $3.81 Million	-130,561 Reduced 6.82%	1,783,271 $50.6 Million
Q4 2023 Feb 09, 2024	BUY	$6.62 - $13.64 $5,799 - $11,948	876 Added 0.05%	1,913,832 $25.5 Million
Q3 2023 Nov 13, 2023	SELL	$8.6 - $12.18 $4,497 - $6,370	-523 Reduced 0.03%	1,912,956 $17.1 Million
Q2 2023 Aug 11, 2023	BUY	$8.53 - $14.28 $180,153 - $301,593	21,120 Added 1.12%	1,913,479 $21.5 Million
Q1 2023 May 12, 2023	BUY	$10.88 - $15.0 $1.24 Million - $1.71 Million	114,058 Added 6.41%	1,892,359 $21.8 Million
Q4 2022 Feb 10, 2023	SELL	$9.37 - $13.8 $42,820 - $63,066	-4,570 Reduced 0.26%	1,778,301 $20.6 Million
Q3 2022 Nov 14, 2022	BUY	$7.2 - $15.17 $262,008 - $552,036	36,390 Added 2.08%	1,782,871 $22.6 Million
Q2 2022 Aug 11, 2022	BUY	$4.36 - $10.5 $2.48 Million - $5.97 Million	568,533 Added 48.26%	1,746,481 $12 Million
Q1 2022 May 13, 2022	SELL	$6.52 - $12.27 $94,214 - $177,301	-14,450 Reduced 1.21%	1,177,948 $11.4 Million
Q4 2021 Feb 11, 2022	BUY	$11.89 - $16.07 $841,633 - $1.14 Million	70,785 Added 6.31%	1,192,398 $14.2 Million
Q3 2021 Nov 12, 2021	BUY	$15.6 - $21.46 $1.34 Million - $1.84 Million	85,666 Added 8.27%	1,121,613 $18.2 Million
Q2 2021 Aug 13, 2021	BUY	$15.94 - $22.33 $1.67 Million - $2.34 Million	104,742 Added 11.25%	1,035,947 $21.8 Million
Q1 2021 May 13, 2021	SELL	$14.0 - $29.3 $7.99 Million - $16.7 Million	-571,000 Reduced 38.01%	931,205 $14.5 Million
Q4 2020 Feb 10, 2021	SELL	$16.81 - $23.94 $4.12 Million - $5.87 Million	-245,352 Reduced 14.04%	1,502,205 $31.5 Million
Q3 2020 Nov 12, 2020	BUY	$20.0 - $23.9 $35 Million - $41.8 Million	1,747,557 New	1,747,557 $35.3 Million

Others Institutions Holding DYN

# of Institutions

218

Shares Held

116M

Call Options Held

322K

Put Options Held

66.2K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $515M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Dyne Therapeutics, Inc. Transaction History